SBIA
BIAF icon

Sheaff Brock Investment Advisors’s bioAffinity Technologies BIAF Stock Holding History

Sheaff Brock Investment Advisors’s Portfolio BIAF Stock Details BIAF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		$14K Buy
1,791
+248
+16% +$4.55K ﹤0.01% 456
2024
Q4 		$42.1K Buy
1,543
+876
+131% +$35.3K ﹤0.01% 447
2024
Q3 		$41.6K Buy
667
+167
+33% +$10K ﹤0.01% 450
2024
Q2 		$32.4K Buy
500
+167
+50% +$11.6K ﹤0.01% 445
2024
Q1 		$20.2K Buy
+333
New +$17.4K ﹤0.01% 506

Other funds holding BIAF

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
CAPTRUST Financial Advisors
CAPTRUST Financial Advisors Raleigh, North Carolina $57.3B AUM 18.32% 1-Year Est. Return
WAM
Warberg Asset Management Winnetka, Illinois $600M AUM 23.37% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VHAM
Van Hulzen Asset Management El Dorado Hills, California $1.35B AUM 22.73% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return

Sheaff Brock Investment Advisors's BIAF Position: Q1 2025 in Review

Sheaff Brock Investment Advisors increased its bioAffinity Technologies (BIAF) stake by 16% in Q1 2025, buying an estimated $4.55K and bringing the position to 1,791 shares worth $14K. The position accounts for ﹤0.01% of the portfolio, ranked #456.

Sheaff Brock Investment Advisors first reported a position in BIAF in Q1 2024 and has held it in 5 quarters since. The position peaked at $42.1K in Q4 2024. 17 funds tracked by Wall St. Rank hold BIAF as of Q1 2025.

  • Sheaff Brock Investment Advisors held 1,791 shares of bioAffinity Technologies worth $14K as of Q1 2025.
  • Sheaff Brock Investment Advisors bought 248 bioAffinity Technologies shares in Q1 2025, an estimated $4.55K.
  • bioAffinity Technologies made up ﹤0.01% of Sheaff Brock Investment Advisors's portfolio in Q1 2025, its #456 holding.
  • Sheaff Brock Investment Advisors first reported a position in bioAffinity Technologies in Q1 2024 and has held it in 5 quarters since.
  • Sheaff Brock Investment Advisors's bioAffinity Technologies position peaked at $42.1K in Q4 2024.
  • 17 funds tracked by Wall St. Rank held bioAffinity Technologies as of Q1 2025.

Based on Sheaff Brock Investment Advisors's 13F filing for Q1 2025, filed 7 May 2025.